Compare Stryker Corporation (SYK) vs Financial Select Sector SPDR Fund (XLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stryker Corporation vs Financial Select Sector SPDR Fund — how do they compare? Stryker Corporation trades at $277.33 (market cap $106.24B), while Financial Select Sector SPDR Fund trades at $54.73 (market cap $50.06B). The key difference: Stryker Corporation is far larger — about 2.1× Financial Select Sector SPDR Fund's market cap, and Stryker Corporation pays a 1.27% dividend while Financial Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Stryker Corporation for 21 Days and Financial Select Sector SPDR Fund for 104 Days on average.
| SYK | XLF | |
|---|---|---|
Market Cap | $106.24B | $50.06B |
Volume | 2,982,001 | 47,464,120 |
Sector | Health | — |
52-Week High | $388.35 | $58.55 |
52-Week Low | $269.75 | $47.80 |
Typical Hold Time | 21 Days | 104 Days |
Enterprise Value | $117.70B | — |
Dividend Yield | 1.27% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stryker (SYK) trades at $277.33, up 0.7% on the day, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279, while fundamentals remain solid with a 14.43% net income margin and strong analyst consensus. Recent news highlights ongoing legal scrutiny related to a manufacturing issue disclosed in September 2026, which caused an 8.8% stock drop, but the company continues to innovate with product launches like Prophecy surgical planning.
The outlook for SYK is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities include robust profitability and growth in medical technology, but risks persist from legal investigations and potential operational disruptions. Investors should weigh strong analyst support against near-term sentiment headwinds.
XLF trades at $54.73, up 1.82% with a bearish technical signal as moving averages and ADX indicators suggest selling pressure. The financial ETF faces sector headwinds with bank stocks lagging the S&P 500 by the widest margin since 1990 despite rising profits. Recent Fed stress test changes and interest rate hikes create both opportunities and challenges for financial sector performance.
Financial sector exposure benefits from rising interest rates but faces regulatory uncertainty and market underperformance risks. The ETF's concentrated 76-holding portfolio offers targeted financial exposure while competing with broader alternatives. Sector rotation into financials by fund managers in Q2 2026 suggests institutional confidence despite recent relative weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →About Financial Select Sector SPDR Fund
The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.
Read more on XLF →
